-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on Axogen, Lowers Price Target to $53

Benzinga·10/01/2026 13:02:29
Diffusion vocale
Truist Securities analyst Ravi Misra maintains Axogen (NASDAQ:AXGN) with a Buy and lowers the price target from $60 to $53.